Trinity Innovation Bioventure Singapore
Founded in 2018, Trinity Innovation Bioventure Singapore (“TIBS”) is dedicated to investing in biomedical innovations. Our limited partners (“LPs”) include renowned biopharmaceutical companies and investment institutions.
Biomedical Industry Focus
Boosting innovation in areas with significant unmet medical needs, TIBS seeks to invest and build great companies that improve the quality of human life. We focus on incubating and growing potential early-stage biotech startups globally and with offices in Beijing, Shanghai and Singapore, we are able to leverage our networks to provide cross-border ecosystems and add value to the companies we invest in.
Our investment team is made up of members with long-standing and proven experience in biopharmaceutical industries where they previously held management roles for Research & Development and business development in multi-national corporations. Prior professorship in prestigious universities and being well versed in the finance sector with fund management experience in top investment institutions, enabled our team to bridge between academia and finance sector. The team has a track record of successful investment cases with a number of recent IPOs.